🔗 Share this article

A shadow economy for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Investigational Drug Gaining Traction Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are encouraged to message these profiles privately for supplier links, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where groups with thousands of members share comparison images, injection guides and assertions of rapid British shipping. Sellers market the substance there before redirecting buyers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Professionals Express Concerns

Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could result in users injecting substances of uncertain source.

Several professionals said the popularity for retatrutide could be linked to the increasing price of licensed weight loss products such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the British medical regulations.

Several content creators attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate medicines, advertising, and consumer regulations, risking fines, legal action or imprisonment.

Service Response and Content Removal

According to the social media company, the platform has taken down problematic content and banned related hashtags and search suggestions. The organization said it was dedicated to maintaining the service secure and investing in strengthening compliance measures.

Digital Trading Operations

Investigations also discovered groups with up to nine thousand members marketing the experimental drug using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly brings up groups with numerous of members, filled with images of weight loss, glowing reviews and step-by-step instructions for preparing or injecting at home.

Within minutes of joining one group, a seller shared contact information, where most purchases occur. The vendor provided an guidebook and promised delivery within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about weight, health issues or previous experience.

Item Information and Costs

Inside these groups, posts display dark colored packages with postal service stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors typically priced at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A representative for the messaging service stated it actively monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering substances they can’t verify. Although the science behind retatrutide is valid, these online versions may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.

Her staff has already encountered individuals harmed by personal administration from unconfirmed sources. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject patients to potentially significant health risks”.